CTB
MYGN icon

Country Trust Bank’s Myriad Genetics MYGN Stock Holding History

Country Trust Bank’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-151
Closed -$4K – 396
2022
Q1 		$4K Hold
151
– – ﹤0.01% 366
2021
Q4 		$4K Hold
151
– – ﹤0.01% 412
2021
Q3 		$5K Buy
+151
New +$5.01K ﹤0.01% 386

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Country Trust Bank's MYGN Position: Q2 2022 in Review

Country Trust Bank sold out of Myriad Genetics (MYGN) in Q2 2022, closing a stake of 151 shares — an estimated $4K sold.

Country Trust Bank first reported a position in MYGN in Q3 2021 and held it in 3 quarters. The position peaked at $5K in Q3 2021. 198 funds tracked by Wall St. Rank hold MYGN as of Q2 2022.

  • Country Trust Bank reported no remaining Myriad Genetics position as of Q2 2022 after selling out during the quarter.
  • Country Trust Bank sold 151 Myriad Genetics shares in Q2 2022, an estimated $4K.
  • Country Trust Bank first reported a position in Myriad Genetics in Q3 2021 and held it in 3 quarters.
  • Country Trust Bank's Myriad Genetics position peaked at $5K in Q3 2021.
  • 198 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2022.

Based on Country Trust Bank's 13F filing for Q2 2022, filed 12 Jul 2022.